The U.S. House of Representatives on Thursday passed H.R. 1899, the Ensuring Compliance Against Drug Diversion Act, introduced by U.S. Rep. Morgan Griffith.
Griffith issued the following statement:
“Registrations to manufacture, distribute, or dispense opioids are not commodities to be bought or sold, but must be earned. The opioid crisis grew in part due to their abuse. My bill, the Ensuring Compliance Against Drug Diversion Act, would provide more accountability in the registration process. I am proud to sponsor this small but important fix that will assist in fighting the opioid epidemic that has hurt too many.”
The Ensuring Compliance Against Drug Diversion Act amends the Controlled Substances Act to prohibit the transfer of any Drug Enforcement Agency registration to manufacture, distribute, or dispense controlled substances without written consent from the agency.
